Top 10 Companies in the (S)-2-Aminobutyramide Hydrochloride (CAS 7682-20-4) Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global (S)-2-Aminobutyramide Hydrochloride (CAS 7682-20-4) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(S)-2-Aminobutyramide Hydrochloride is a chiral amino acid derivative and an important pharmaceutical intermediate, recognized for its role in the synthesis of active pharmaceutical ingredients (APIs), particularly in the development of antiepileptic drugs such as levetiracetam. The compound, identified by CAS number 7682-20-4, carries a free amine group and an amide functional group, making it highly versatile in asymmetric synthesis and peptide chemistry applications.

The market is witnessing steady growth driven by rising global demand for chiral building blocks in pharmaceutical manufacturing, increasing prevalence of neurological disorders, and expanding investments in fine chemical and contract research organization (CRO) sectors. Furthermore, the growing emphasis on enantioselective synthesis and regulatory preference for single-enantiomer drugs continues to strengthen demand for this compound across research and industrial‑scale production environments.

---

10️⃣ 1. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Pharmaceutical‑grade chiral intermediates, process development, and custom synthesis services

Evonik is a global leader in specialty chemicals and has a dedicated chiral chemistry division that produces high‑purity (S)-2‑Aminobutyramide Hydrochloride at commercial scale. The company leverages advanced asymmetric synthesis technologies and robust quality assurance to meet stringent ICH and USP standards, making it a trusted supplier for levetiracetam manufacturers worldwide.

Sustainability & Growth Initiatives:

• Investing in green catalytic processes to reduce solvent usage and waste generation
• Expanding contract manufacturing capabilities in Asia‑Pacific to serve growing generic markets
• Continuous improvement of GMP documentation and DMF filing support for global customers

---

9️⃣ 2. Aurobindo Pharma Limited

Headquarters: Bangalore, India
Key Offering: Bulk API manufacturing, chiral intermediates, and contract development & manufacturing organization (CDMO) services

Aurobindo has rapidly expanded its chiral chemistry portfolio to support levetiracetam production for the global generic market. The company’s integrated supply chain and in‑house analytical capabilities enable rapid scale‑up and stringent quality control, positioning it as a preferred partner for multinational pharmaceutical firms.

Sustainability & Growth Initiatives:

• Adoption of continuous flow chemistry for chiral resolution to improve yield and reduce energy consumption
• Strategic partnerships with local universities to foster talent development in asymmetric synthesis
• Implementation of ISO 14001 environmental management systems across manufacturing sites

---

8️⃣ 3. Jiangsu Hihi Chemical Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Pharmaceutical‑grade chiral intermediates, custom synthesis, and analytical support

Jiangsu Hihi specializes in chiral resolution of amino acid derivatives and has a strong presence in the Chinese and ASEAN markets. The company’s state‑of‑the‑art chiral HPLC and enzymatic resolution facilities ensure consistent optical purity for levetiracetam and other CNS APIs.

Sustainability & Growth Initiatives:

• Development of bio‑based catalysts to replace hazardous reagents
• Expansion of export capacity to meet growing demand from Europe and North America
• Investment in digital quality management systems for real‑time process monitoring

---

7️⃣ 4. Vasudha Pharma Chem Limited

Headquarters: Bangalore, India
Key Offering: Fine chemical manufacturing, chiral intermediates, and CDMO services

Vasudha Pharma Chem provides high‑purity chiral building blocks to the global pharmaceutical industry, with a focus on levetiracetam and related antiepileptic drugs. The company’s robust quality system and in‑house DMF preparation support fast market entry for new APIs.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recovery systems
• Collaboration with academic partners on green chemistry research
• Expansion of contract manufacturing facilities in Tier‑2 Indian cities

---

6️⃣ 5. Zhangjiagang Specom Biochemical Co., Ltd.

Headquarters: Zhangjiagang, China
Key Offering: Bulk chiral intermediates, API manufacturing, and custom synthesis

Specom Biochemical is a leading supplier of (S)-2‑Aminobutyramide Hydrochloride in China, serving both domestic and export markets. Its integrated process development and scale‑up capabilities allow rapid response to market demand for levetiracetam and other CNS drugs.

Sustainability & Growth Initiatives:

• Adoption of continuous manufacturing for chiral resolution to reduce batch variability
• Investment in renewable energy sources for plant operations
• Strengthening supply chain resilience through dual‑sourcing strategies

---

5️⃣ 6. Jiangsu Yida Chemical Co., Ltd.

Headquarters: Suzhou, China
Key Offering: Pharmaceutical‑grade chiral intermediates, analytical services, and contract manufacturing

Yida Chemical focuses on delivering high‑purity chiral building blocks for the global API market. Its advanced chiral resolution processes and rigorous quality controls ensure compliance with ICH Q7 and USP standards.

Sustainability & Growth Initiatives:

• Implementation of green chemistry protocols to minimize hazardous waste
• Expansion of production capacity in response to rising generic demand
• Digital transformation of quality management for real‑time compliance monitoring

---

4️⃣ 7. Haihang Industry Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Fine chemical manufacturing, chiral intermediates, and custom synthesis solutions

Haihang Industry supplies high‑purity (S)-2‑Aminobutyramide Hydrochloride to pharmaceutical companies worldwide. The firm’s expertise in chiral synthesis and robust analytical capabilities support fast, compliant API development.

Sustainability & Growth Initiatives:

• Adoption of solvent‑free synthesis routes where feasible
• Strategic partnerships with global CDMOs to enhance market reach
• Continuous improvement of GMP compliance and traceability systems

---

3️⃣ 8. Hangzhou Hairui Chemical Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Pharmaceutical‑grade chiral intermediates, analytical support, and CDMO services

Hairui Chemical delivers high‑purity chiral building blocks for levetiracetam and other CNS APIs. Its integrated process development and quality assurance infrastructure enable rapid scale‑up and regulatory compliance.

Sustainability & Growth Initiatives:

• Investment in biocatalytic resolution to reduce energy consumption
• Expansion of export capacity to meet European and North American demand
• Implementation of ISO 9001 and ISO 14001 certifications across facilities

---

2️⃣ 9. Dr. Reddy’s Laboratories

Headquarters: Hyderabad, India
Key Offering: Bulk API manufacturing, chiral intermediates, and contract development services

Dr. Reddy’s has a strong focus on CNS drug development and has integrated (S)-2‑Aminobutyramide Hydrochloride into its levetiracetam production line. The company’s robust quality system and global distribution network support consistent supply to multinational customers.

Sustainability & Growth Initiatives:

• Implementation of continuous flow chemistry for chiral resolution
• Strategic investments in green chemistry research and development
• Expansion of CDMO capabilities to serve emerging markets

---

1️⃣ 10. Hetero Labs

Headquarters: Chennai, India
Key Offering: Fine chemical manufacturing, chiral intermediates, and custom synthesis

Hetero Labs supplies high‑purity (S)-2‑Aminobutyramide Hydrochloride to the global pharmaceutical industry, focusing on levetiracetam and other CNS APIs. The company’s integrated quality and process development teams ensure compliance with global regulatory standards.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources for manufacturing operations
• Investment in process analytical technology for real‑time monitoring
• Expansion of contract manufacturing capacity to meet rising generic demand

---

Download FREE Sample Report: (S)-2-Aminobutyramide Hydrochloride (CAS 7682-20-4) Market – View in Detailed Research Report

Get Full Report Here: (S)-2-Aminobutyramide Hydrochloride (CAS 7682-20-4) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of (S)-2-Aminobutyramide Hydrochloride Market Is Growing

The (S)-2‑Aminobutyramide Hydrochloride market is poised for sustained expansion driven by the continued demand for levetiracetam, the growing focus on single‑enantiomer drugs, and the expansion of generic pharmaceutical manufacturing in emerging economies. As regulatory agencies worldwide tighten chiral purity requirements, manufacturers are investing in advanced asymmetric synthesis and continuous manufacturing technologies to meet these standards while controlling costs.

📈 Key Trends Shaping the Market:

• Rapid adoption of continuous flow chemistry and green catalytic processes to improve yield and reduce environmental impact.
• Increased collaboration between fine chemical suppliers and CDMOs to provide end‑to‑end chiral intermediate solutions.
• Expansion of dual‑sourcing strategies by pharmaceutical companies to mitigate supply chain risks.
• Growing emphasis on digital quality management systems for real‑time compliance monitoring.
• Emergence of new therapeutic areas such as peptide‑based CNS drugs that may increase demand for chiral building blocks.

These trends collectively reinforce the market’s growth trajectory and underscore the importance of technical expertise, quality assurance, and supply chain resilience in securing a competitive position within the industry.